Navigation Links
Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng
Date:7/14/2011

SAN DIEGO, July 14, 2011 /PRNewswire/ -- Naviscan, Inc., the worldwide leader in 3D Molecular Breast Imaging (MBI), announced today that Andre Cheng MD, PhD has joined the Naviscan Board of Directors.

Dr. Cheng has extensive clinical and business experience related to reimbursement in the medical device industry.  He served as the Vice President of Medical Affairs and Reimbursement at Acclarent, Inc.  After acquisition by Ethicon, Inc., a Johnson & Johnson company, he served as Worldwide Vice President of Health Economics and Reimbursement at Ethicon.  Prior to this he was a Managing Partner at The Advisory Board Company.  Dr. Cheng is a graduate of the Johns Hopkins School of Medicine and holds a PhD in Clinical Investigation and Healthcare Economics from the Johns Hopkins School of Public Health.

"Dr. Cheng is an acknowledged physician and scientist with extensive, relevant expertise and a track record of extraordinary success in securing reimbursement for new technologies," stated Paul Mirabella, Chairman and CEO.  "As we expand our global reach and market penetration into new areas of the patient care cycle, adding Andre to our Board will further strengthen Naviscan's already solid reimbursement and clinical impact."

Naviscan manufactures the only commercially-available organ-specific, high resolution PET scanner, the breast applications for which are Positron Emission Mammography (PEM) and PEM-guided biopsy.  The scanner uses PET technology to produce tomographic images that allow physicians to visualize and biopsy breast tumors as small as 1.3 mm.  In recently published data, PEM has been found to be significantly more precise at identifying benign and cancerous lesions—what scientists call "specificity"—and therefore has the potential to reduce the number of unnecessary biopsies.  This finding is a welcomed outcome for women and physicians looking for ways to reduce the patient trauma and cost associated with unnecessary procedures.  

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call 1.858.587.3641 or visit www.naviscan.com


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
2. Baylor Adds Naviscan PEM Technology to Womens Imaging Center
3. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
4. Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
5. SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services
6. Naviscan® Announces Collaboration With Neoprobe Corporation to Enable Pipeline Technology Development
7. Naviscan Announces European Launch of Positron Emission Mammography
8. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
9. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
10. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
11. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):